Gilead
-
Gilead says counterfeit versions of its HIV drug were sold to patients over past 2 yearsThe drugmaker said it found 85,247 bottles that had been tampered with or faked, including versions of its Biktarvy and Descovy treatments.HealthJan 19, 2022
-
Remdesivir not recommended for hospitalized coronavirus patients, WHO saysThe advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.WorldNov 19, 2020
-
Remdesivir cut coronavirus recovery time by 5 days, company’s final study suggestsThe antiviral drug, which was recently used to treat U.S. President Donald Trump, also appeared to reduce the risk of death in some patients.HealthOct 8, 2020
![]()
-
U.S. buys up worldwide stock of remdesivir, drug seen as potential COVID-19 treatmentThe Department of Health and Human Services has secured more than 500,000 treatment courses of the drug from its sole manufacturer Gilead for American hospitals through September.HealthJun 30, 2020
![]()
-
Coronavirus drug remdesivir to cost $2,340 per patient in the U.S.The amount that patients pay out of pocket depends on insurance, income and other factors.WorldJun 29, 2020
![]()
-
Remdesivir, hailed as potential COVID-19 treatment, gets emergency U.S. FDA green lightAn emergency use authorization by the FDA is not the same as drug approval.HealthMay 1, 2020
![]()
-
Experimental drug proven effective against coronavirus, biotech company saysGilead Sciences’s remdesivir would be the first treatment to pass such a test against the virus, which has killed more than 218,000 people since it emerged late last year in China.ScienceApr 29, 2020
![]()
-
Coronavirus: Drug trial sees ‘encouraging’ results but researchers say more study neededNearly 70 per cent of patients tested in the U.S., Europe, Canada and Japan improved after taking the Gilead Sciences drug remdesivir, but eight of the patients worsened while seven died.HealthApr 10, 2020
![]()
